Effect of atropine 0.01% on progression of myopia

Effect of atropine 0.01% on progression of myopia - PMC

This study was done to determine the effect of atropine 0.01% eye drops on the progression of myopia in children >5 years.

This study was done to determine the effect of atropine 0.01% eye drops on the progression of myopia in children >5 years.

Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment ...

Low-dose atropine, at concentrations up to 0.05%, has recently emerged as a pharmacologic option to control myopia progression in children. The ...

Effect of atropine 0.01% on myopia control in children aged 6–13 ...

Conclusion: Children treated with 0.01% atropine had slower myopia progression during the lockdown period in Shanghai compared with children ...

Low-dose atropine eyedrops no better than placebo for slowing ...

Much stronger concentrations of atropine eyedrops (0.5-1.0%) have long been used by pediatric eye doctors to slow myopia progression. While ...

Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

A dose-dependent effect has been noted with 0.025% and 0.05% concentrations performing better than 0.01% for 1-year myopic progression in the ...

Atropine 0.01% Eye Drops Did Not Slow Myopia Progression ...

The current study looked at the effects of atropine 0.01% eye drops in a US-based pediatric population. Study Design. This was a randomized ...

Atropine eye drops for myopia control in children | My Kids Vision

Atropine eye drops can be used to test and treat various eye conditions, and in low concentrations can slow myopia progression in children from age 4.

Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2

Over 5 years, atropine 0.01% eyedrops were more effective in slowing myopia progression with less visual side effects compared with higher doses of atropine.

How to Use Low-Dose Atropine to Slow Myopic Progression in Kids

Siatkowski, low-dose atropine has slowed the rate of myopic progression in his patients by between 30% and 50%. And 2 patients have had complete ...

In our case, we found that atropine 0.01% had similar effect during the first and second year of treatment in terms of mean SE progression (− ...

Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop ...

There may be a modest but clinically relevant reduction in myopia progression in Danish children after twelve months treatment, but the effect ...

Low-dose (0.01%) atropine eye-drops to reduce progression of ...

Atropine at low concentration has been shown to be safe and effective in slowing myopia progression in children of Chinese ethnicity,13–17 but its safety and ...

Safety and efficacy of 0.02% and 0.01% atropine on controlling ...

Treatment with 0.02% or 0.01% atropine controlled myopia progression and AL elongation synchronously and had similar effects on myopia control ...

Topical Atropine in the Control of Myopia - ScienceDirect.com

Topical atropine reduces myopia progression and axial elongation in children in a dose-related manner, but a rebound phenomenon occurs with higher doses.

Atropine 0.01% Eye Drops for Myopia Control in American Children

Similar to results reported in Asia, atropine 0.01% eye drops significantly reduced myopia progression in a cohort of US children over 2 years ...

Myopia progression following 0.01% atropine cessation in ...

A rebound in myopia progression following cessation of atropine eyedrops has been reported, yet there is limited data on the effects of ...

(PDF) Effect of atropine 0.01% on progression of myopia PMID: *****

There was an average 0.7 mm increase in pupillary size posttreatment in the atropine group. Conclusions The results of our study indicated that ...

Effects of atropine 0.01% on refractive errors in children with myopia

Atropine 0.01% was effective in preventing myopia progression, whereas 9 months of atropine treatment resulted in a clinically small, but statistically ...

Myopia progression after cessation of atropine in children - Frontiers

Results: The analysis included 13 studies involving 2060 children. Rebound effects on SE were significantly higher at 6 months (WMD, 0.926 D/y; ...